Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...

Nona Biosciences is a global biotechnology company committed to cutting-edge technology innovations and providing integrated solutions from I to I (R) (Idea to IND), ranging from target validation and ...

Learn about women in STEM and the vital role of Dr Lidia Serina in advancing biopharma therapies and empowering women.

For Patrick Flanagan, CEO of Veristat, optimism will drive new financial growth.“The coming year will mark a new era of ...

Chong Kun Dang recently announced plans to invest 2.2 trillion Korean won in establishing a state-of-the-art ...

Researchers have developed a TRBC2-targeted antibody-drug conjugate for T-cell lymphomas and leukemias, addressing half of ...

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care chemotherapy and a manageable safety profile in the first ...

Proteins are among the most important molecular building blocks of life. They are chains of amino acids assembled in our cells by ribosomes, the molecular "protein factories" of our bodies. The ...

A research team at Duke University has developed a new AI framework that can uncover simple, understandable rules that govern ...

The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to 30+ ...

At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...

The global antibody optimization service market size was valued at USD 2.77 billion in 2024 and is predicted to hit around ...